Germany
Japan
United Kingdom
China
Rabbit polyclonal anti-ARSK antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from C-terminal of human ARSK. |
Antibodies
View as table Download
Anti-AGT Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 34-43 amino acids of human angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
Anti-AGT Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 34-43 amino acids of human angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
Anti-APOA1 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 14-267 amino acids of human apolipoprotein A-I |
Anti-F13A1 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 250 amino acids of human coagulation factor XIII, A1 polypeptide |
Anti-F9 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 227-461 amino acids of human coagulation factor IX |
Anti-FGFR2 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 809-821 amino acids of Human Fibroblast growth factor receptor 2 |
Anti-SERPINA1 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 25-307 amino acids of human serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
Anti-SERPINC1 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 15-259 amino acids of human serpin peptidase inhibitor, clade C (antithrombin), member 1 |
Anti-IGFBP1 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide peptide corresponding to a region derived from 237-249 amino acids of human insulin-like growth factor binding protein 1 |
Anti-ANXA2 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Full length fusion protein |
Anti-TF Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 562-577 amino acids of Human Transferrin |
Anti-AFP Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 350 amino acids of Human Alpha-fetoprotein |
Anti-ANGPT1 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Full length fusion protein |
Anti-BMP3 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 363-472 amino acids of human bone morphogenetic protein 3 |
Anti-BMP3 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 23-42 amino acids of Human Bone morphogenetic protein 3 |
Anti-AMPH Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 250 amino acids of human amphiphysin |
Anti-FGF7 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 179-182 amino acids of Human Fibroblast growth factor 7 |
Anti-NPPB Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 77-90 amino acids of Human natriuretic peptide B |
Anti-PTHLH Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 37-177 amino acids of human parathyroid hormone-like hormone |
Anti-CCL2 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 75-89 amino acids of Human C-C motif chemokine 2 |
Anti-SFTPD Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 260-375 amino acids of human surfactant protein D |
Anti-ANGPTL1 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 143-491 amino acids of human angiopoietin-like 1 |
Anti-MSTN Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 354-366 amino acids of Human myostatin |
Anti-VEGFC Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 256-270 amino acids of human vascular endothelial growth factor C |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Rat
Applications
- IHC
Antibody Hosts
- Rabbit
Conjugates
- Unconjugated
Families
- Secreted Protein
Availabilities
- In Stock
Filter by
Target Symbol
- GCG (4)
- LOX (4)
- ADM (3)
- AFP (3)
- AGT (3)
- BMP3 (3)
- DEFA1 (3)
- EIF2AK3 (3)
- GNAS (3)
- ACE2 (2)
- ADAMTSL1 (2)
- ADCK1 (2)
- AGRP (2)
- AMH (2)
- AMPH (2)
- ANGPT1 (2)
- ANGPTL4 (2)
- ANXA2 (2)
- APOA1 (2)
- APOH (2)
- ARSK (2)
- BDNF (2)
- BPIFB2 (2)
- CCL17 (2)
- COX16 (2)
- CRP (2)
- ERBB3 (2)
- F13A1 (2)
- FAM3A (2)
- FBLN1 (2)
- FGF7 (2)
- FGFR2 (2)
- FN1 (2)
- GABBR1 (2)
- GAS6 (2)
- GSN (2)
- IGFBP7 (2)
- IL18BP (2)
- IL20 (2)
- INHA (2)
- LAMA3 (2)
- LGALS3 (2)
- MUC1 (2)
- PON1 (2)
- PRL (2)
- PSPN (2)
- PTHLH (2)
- RETN (2)
- RETNLB (2)
- SCG3 (2)
- SCT (2)
- SERPINA1 (2)
- SERPINC1 (2)
- SFRP1 (2)
- SFTPD (2)
- SHBG (2)
- SHH (2)
- SPATA6 (2)
- STX1A (2)
- SYT6 (2)
- TFPI2 (2)
- TNF (2)
- TNFRSF11B (2)
- TNFSF13 (2)
- UCN (2)
- UTS2 (2)
- VGF (2)
- A1BG (1)
- ABO (1)
- ACE (1)
- ADAM28 (1)
- ADAMTS1 (1)
- ADAMTS10 (1)
- ADAMTS18 (1)
- ADAMTS19 (1)
- ADAMTS5 (1)
- ADM2 (1)
- AGR2 (1)
- AGR3 (1)
- ANGPT4 (1)
- ANGPTL1 (1)
- ANGPTL2 (1)
- APLN (1)
- ATRN (1)
- B2M (1)
- BGLAP (1)
- BGN (1)
- BMP4 (1)
- BPIFB1 (1)
- BPIFB3 (1)
- C1QTNF5 (1)
- CALR (1)
- CALU (1)
- CBLN1 (1)
- CCL15 (1)
- CCL2 (1)
- CCL26 (1)
- CCL4 (1)
- CCL7 (1)
- CCN1 (1)
Clonalities
Modifications
Pathways
- Cytokine-cytokine receptor interaction (36)
- Pathways in cancer (29)
- MAPK signaling pathway (21)
- Regulation of actin cytoskeleton (17)
- Complement and coagulation cascades (14)
- Jak-STAT signaling pathway (10)
- TGF-beta signaling pathway (10)
- Focal adhesion (9)
- Melanoma (9)
- Neuroactive ligand-receptor interaction (9)
- Chemokine signaling pathway (8)
- Adipocytokine signaling pathway (7)
- Alzheimer's disease (7)
- ECM-receptor interaction (7)
- Hematopoietic cell lineage (7)
- Apoptosis (6)
- Dilated cardiomyopathy (6)
- Metabolic pathways (6)
- Renin-angiotensin system (6)
- Toll-like receptor signaling pathway (6)
- Basal cell carcinoma (5)
- Calcium signaling pathway (5)
- Endocytosis (5)
- Hedgehog signaling pathway (5)
- Melanogenesis (5)
- NOD-like receptor signaling pathway (5)
- Neurotrophin signaling pathway (5)
- PPAR signaling pathway (5)
- Prostate cancer (5)
- Type I diabetes mellitus (5)
- Wnt signaling pathway (5)
- Allograft rejection (4)
- ErbB signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- GnRH signaling pathway (4)
- Graft-versus-host disease (4)
- Hypertrophic cardiomyopathy (HCM) (4)
- Long-term depression (4)
- Pancreatic cancer (4)
- Renal cell carcinoma (4)
- Small cell lung cancer (4)
- Amyotrophic lateral sclerosis (ALS) (3)
- Asthma (3)
- Axon guidance (3)
- Bladder cancer (3)
- Gap junction (3)
- Natural killer cell mediated cytotoxicity (3)
- SNARE interactions in vesicular transport (3)
- Systemic lupus erythematosus (3)
- Taste transduction (3)
- Type II diabetes mellitus (3)
- Vascular smooth muscle contraction (3)
- Vibrio cholerae infection (3)
- mTOR signaling pathway (3)
- p53 signaling pathway (3)
- Antigen processing and presentation (2)
- Autoimmune thyroid disease (2)
- Cytosolic DNA-sensing pathway (2)
- Fc epsilon RI signaling pathway (2)
- Huntington's disease (2)
- Maturity onset diabetes of the young (2)
- RIG-I-like receptor signaling pathway (2)
- T cell receptor signaling pathway (2)
- Cell adhesion molecules (CAMs) (1)
- Cell cycle (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Glioma (1)
- Glycosaminoglycan degradation (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Histidine metabolism (1)
- Insulin signaling pathway (1)
- N-Glycan biosynthesis (1)
- Non-small cell lung cancer (1)
- Oocyte meiosis (1)
- Primary immunodeficiency (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Regulation of autophagy (1)
- VEGF signaling pathway (1)
- Viral myocarditis (1)
- beta-Alanine metabolism (1)